Ifosfamide treatment as a 10-day continuous intravenous infusion.
about
Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapyEvaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerEncapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancerOptimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.New investigations into the stability of Mesna using LC-MS/MS and NMR.
P2860
Ifosfamide treatment as a 10-day continuous intravenous infusion.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@ast
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@en
type
label
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@ast
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@en
prefLabel
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@ast
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@en
P2093
P356
P1476
Ifosfamide treatment as a 10-day continuous intravenous infusion.
@en
P2093
Ouwerkerk J
Welvaart K
van der Velde CJ
P2888
P304
P356
10.1007/BF01209597
P577
1995-01-01T00:00:00Z